Cargando…

Künstliche Intelligenz in der Neurointensivmedizin

Artificial intelligence (AI) has been introduced into medicine and an AI-assisted medicine will be the future that we should help to shape. In particular, supervised, unsupervised, and reinforcement learning will be the main methods to play a role in the implementation of AI. Severely ill patients a...

Descripción completa

Detalles Bibliográficos
Autores principales: Schweingruber, N., Gerloff, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829030/
https://www.ncbi.nlm.nih.gov/pubmed/33491152
http://dx.doi.org/10.1007/s00115-020-01050-4
_version_ 1783641104136011776
author Schweingruber, N.
Gerloff, C.
author_facet Schweingruber, N.
Gerloff, C.
author_sort Schweingruber, N.
collection PubMed
description Artificial intelligence (AI) has been introduced into medicine and an AI-assisted medicine will be the future that we should help to shape. In particular, supervised, unsupervised, and reinforcement learning will be the main methods to play a role in the implementation of AI. Severely ill patients admitted to the intensive care unit (ICU) are closely monitored in order to be able to quickly respond to any changes. These monitoring data can be used to train AI models to predict critical phases in advance, making an earlier reaction possible. To achieve this a large amount of clinical data are needed in order to train models and an external validation on independent cohorts should take place. Prospective studies with treatment of patients admitted to the ICU with AI assistance should show that they provide a benefit for patients. We present the most important resources from de-identified (anonymized) patient data on open-source use for AI research in intensive care medicine. The focus is on neurological diseases in the ICU, therefore, we provide an overview of existing models for prediction of outcome, vasospasms, intracranial pressure and levels of consciousness. To introduce the advantages of AI in the clinical routine, more AI-based models with larger datasets will be needed. To achieve this international cooperation is absolutely necessary. Clinical centers associated with universities are needed to provide a constant validation of applied models as these models can change during use or a bias can develop during the training. A strong commitment to AI research is important for Germany, not only with respect to academic achievements but also in the light of a rapidly growing influence of AI on the economy.
format Online
Article
Text
id pubmed-7829030
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Medizin
record_format MEDLINE/PubMed
spelling pubmed-78290302021-01-25 Künstliche Intelligenz in der Neurointensivmedizin Schweingruber, N. Gerloff, C. Nervenarzt Leitthema Artificial intelligence (AI) has been introduced into medicine and an AI-assisted medicine will be the future that we should help to shape. In particular, supervised, unsupervised, and reinforcement learning will be the main methods to play a role in the implementation of AI. Severely ill patients admitted to the intensive care unit (ICU) are closely monitored in order to be able to quickly respond to any changes. These monitoring data can be used to train AI models to predict critical phases in advance, making an earlier reaction possible. To achieve this a large amount of clinical data are needed in order to train models and an external validation on independent cohorts should take place. Prospective studies with treatment of patients admitted to the ICU with AI assistance should show that they provide a benefit for patients. We present the most important resources from de-identified (anonymized) patient data on open-source use for AI research in intensive care medicine. The focus is on neurological diseases in the ICU, therefore, we provide an overview of existing models for prediction of outcome, vasospasms, intracranial pressure and levels of consciousness. To introduce the advantages of AI in the clinical routine, more AI-based models with larger datasets will be needed. To achieve this international cooperation is absolutely necessary. Clinical centers associated with universities are needed to provide a constant validation of applied models as these models can change during use or a bias can develop during the training. A strong commitment to AI research is important for Germany, not only with respect to academic achievements but also in the light of a rapidly growing influence of AI on the economy. Springer Medizin 2021-01-24 2021 /pmc/articles/PMC7829030/ /pubmed/33491152 http://dx.doi.org/10.1007/s00115-020-01050-4 Text en © Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Leitthema
Schweingruber, N.
Gerloff, C.
Künstliche Intelligenz in der Neurointensivmedizin
title Künstliche Intelligenz in der Neurointensivmedizin
title_full Künstliche Intelligenz in der Neurointensivmedizin
title_fullStr Künstliche Intelligenz in der Neurointensivmedizin
title_full_unstemmed Künstliche Intelligenz in der Neurointensivmedizin
title_short Künstliche Intelligenz in der Neurointensivmedizin
title_sort künstliche intelligenz in der neurointensivmedizin
topic Leitthema
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829030/
https://www.ncbi.nlm.nih.gov/pubmed/33491152
http://dx.doi.org/10.1007/s00115-020-01050-4
work_keys_str_mv AT schweingrubern kunstlicheintelligenzinderneurointensivmedizin
AT gerloffc kunstlicheintelligenzinderneurointensivmedizin